Article

Genome-wide Analysis Reflects Novel 5-Hydroxymethylcytosines Implicated in Diabetic Nephropathy

2022-01-15

Abstract excerpt

<h4>ABSTRACT</h4> Long-term complications of type 2 diabetes (T2D) are the major causes for T2D-related disability and mortality. Notably, diabetic nephropathy (DN) has become the most frequent cause of end-stage renal disease (ESRD) in most countries. Understanding epigenetic contributors to DN can provide novel insights into this complex disorder and lay the foundation for more effective monitoring tools and pre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 86acee27-c70e-5c38-8568-230d5f7ecc86
DOI: 10.1101/2022.01.14.22269066

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genome-wide Analysis Reflects Novel 5-Hydroxymethylcytosines Implicated in Diabetic NephropathyDOI 10.1101/2022.01.14.22269066Read

5-Hydroxymethylcytosine Profiles in Plasma Cell-free DNA Reflect Molecular Characteristics of Diabetic Kidney DiseaseSemantic proximity Read

5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney diseaseSemantic proximity Read

DNA 5-Hydroxymethylcytosines from Cell-free Circulating DNA as Diagnostic Biomarkers for Human CancersSemantic proximity Read

DNA Methylation Changes Associated With Type 2 Diabetes and Diabetic Kidney Disease in an East Asian Population.Semantic proximity Read

5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stagesSemantic proximity Read

DNA methylation profiling of CD04+/CD08+ T cells reveals pathogenic mechanisms in increasing hyperglycemia: PIRAMIDE pilot studySemantic proximity Read

Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney diseaseSemantic proximity Read

5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer’s DiseaseSemantic proximity Read

CTSS and CD53: Emerging m6A methylation markers in diabetic kidney disease pathogenesis and their clinical implicationsSemantic proximity Read

Epigenetics in the pathogenesis of diabetic nephropathySemantic proximity Read

Epigenetic Regulations in Diabetic Nephropathy.Semantic proximity Read

Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetesSemantic proximity Read